NMIC Bulletin Vol. 29 No. 1 Use of Medicines in Children

18 January, 2023

Use of Medicines in Children

  • Many medicines have not undergone extensive evaluation in children and the “off-label or unlicensed” use of medicines in children is common
  • Children are particularly susceptible to adverse drug reactions and medication errors
  • The dose of a medicine, based on age and/or weight, needs to be individualised to the child using a reliable paediatric medicines information resource
  • Good communication is important between all healthcare professionals involved in the child’s treatment and with the parents/carers